FARALLON CAPITAL MANAGEMENT, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000909661

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Tom Steyer — tracked via quarterly SEC 13F filings · All famous investors

LargeFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 109 positions · Total reported value $22.58B · Top-10 concentration 62.3% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 64.4% · 43 new · 19 cut · 23 exited

Active Share (vs S&P 500): 91.2% · vs QQQ: 92.5% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. disclosed 109 equity positions with a combined reported value of $22.58B. The filing implies a focused portfolio: its ten largest positions account for 62.3% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B). By sector, the heaviest allocations are Health Care 51.5%, Communication Services 9.6%. Versus the prior quarter, allocation shifted toward Communication Services (+6.3pp), Health Care (+3.3pp) and away from Other (-11.2pp).

Versus the prior quarter, FARALLON CAPITAL MANAGEMENT, L.L.C. opened 43 new positions, trimmed 19 and fully exited 23, a turnover rate of 64.4% of positions. The portfolio's overlap with the prior quarter was 50% of names.

The largest new positions opened in Q3 2026 were ROKU ($633.49M), CRH ($442.24M), IONI ($57.69M).

Of the 23 positions fully exited versus the prior quarter, the largest were EA ($1.62B), CRNX ($336.37M), APGE ($140.69M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ROKU ROKU INC · $633.49M
  • CRH CRH PLC · $442.24M
  • IONI IONIC DIGITAL INC · $57.69M
  • IBIT ISHARES BITCOIN TRUST ETF · $43.40M
  • LBRX LB PHARMACEUTICALS INC · $28.46M
  • IMCR IMMUNOCORE HLDGS PLC · $28.11M
  • ASML ASML HLDG NV · $24.49M
  • BABA ALIBABA GROUP HLDG LTD · $20.33M

Fully Exited (vs previous quarter)

  • EA ELECTRONIC ARTS INC · prev qtr: $1.62B
  • CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $336.37M
  • APGE APOGEE THERAPEUTICS INC · prev qtr: $140.69M
  • NVO NOVO-NORDISK A S · prev qtr: $125.55M
  • SOXX ISHARES TR · prev qtr: $83.30M
  • CGON CG ONCOLOGY INC · prev qtr: $28.42M
  • MRK MERCK & CO INC · prev qtr: $25.57M
  • WRBY WARBY PARKER INC · prev qtr: $25.12M

Insider Transactions (Form 4)

Latest Tom Steyer buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Farallon Capital Management is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 86 US equity positions with a combined value of $21.54B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-51763 (status: Approved), registered 1996-04-01
  • Regulatory AUM (Form ADV): $52.08B as of 2026-09-23
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 50 private funds, of which 50 hedge funds
  • Website: faralloncapital.com

Portfolio Structure

  • 86 positions · $21.54B reported value (Q2 2026)
  • Top 10 holdings = 62.5% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 20.8%
  • Average position size: $250.46M

Sector Tilt

  • Health Care 51.2%
  • Information Technology 6.7%
  • Consumer Discretionary 4.0%
  • (classified holdings cover 70% of value)

Quarterly Activity

  • Q2 2026: 20 new, 29 added, 23 reduced, 103 exited
  • 14 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure to large-cap passive ETF (SPY) and some mega-cap stocks (AMZN), while adding to healthcare and communication services stocks, suggesting a tilt toward active, high-growth sectors with potential upside. 2. Key moves: - Reduced: SPY (by 13.0% shares), AMZN (by 10.0% shares), RVMD (by 1.0% shares). - Added: WBD (+75.7% shares), NTRA (+17.2% shares), BBIO (+32.6% shares), PTGX (+1.4% shares), EXEL (+9.1% shares), ROIV (+52.0% shares). - New: ROKU (new position). 3. Portfolio structure: Active, with a heavy bias toward healthcare (60% of top 10) and communication services; reduced passive exposure, indicating higher risk appetite for growth stocks. 4. Per-holding one-liner: - SPY: S&P 500 ETF (unverified benchmark). - RVMD: Cancer drug developer (Health Care). - WBD: Media/entertainment conglomerate (Communication Services). - NTRA: Genetic testing firm (Health Care). - BBIO: Gene therapy developer (Health Care). - PTGX: Autoimmune drug developer (Health Care). - EXEL: Cancer drug developer (Health Care). - ROIV: Biotech drug developer (Health Care). - ROKU: Streaming TV platform (Communication Services). - AMZN: E-commerce giant (Consumer Discretionary). 5. Style summary: Rotated from passive large-caps to concentrated healthcare and communication services bets, favoring high-growth biotech and media stocks.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 03:47

Sector Allocation

Health Care 51.5%
Technology 6.8%
Financials 3.4%
Materials 0.1%
Other 18.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 5.22M $3.98B 17.63%
17.63%
Reduce
2 13.42M $2.75B 12.20%
12.20%
Reduce
3 49.37M $1.53B 6.77%
6.77%
Add
4 2.60M $1.07B 4.76%
4.76%
Add
5 14.25M $937.45M 4.15%
4.15%
Add
6 6.44M $907.04M 4.02%
4.02%
Add
7 14.69M $858.33M 3.80%
3.80%
Add
8 21.75M $795.23M 3.52%
3.52%
Add
9 4.16M $633.49M 2.81%
2.81%
New
10 2.37M $590.10M 2.61%
2.61%
Reduce
11 4.07M $570.18M 2.52%
2.52%
Reduce
12 11.29M $492.68M 2.18%
2.18%
Add
13 1.40M $490.19M 2.17%
2.17%
Add
14 5.34M $442.24M 1.96%
1.96%
New
15 25.02M $441.76M 1.96%
1.96%
Hold
16 2.14M $412.84M 1.83%
1.83%
Hold
17 1.05M $384.93M 1.71%
1.71%
Reduce
18 733.56K $376.24M 1.67%
1.67%
Reduce
19 857.89K $373.13M 1.65%
1.65%
Add
20 3.88M $354.25M 1.57%
1.57%
Reduce
21 1.24M $343.10M 1.52%
1.52%
Reduce
22 3.11M $309.66M 1.37%
1.37%
Reduce
23 445.69K $300.86M 1.33%
1.33%
Reduce
24 8.91M $269.50M 1.19%
1.19%
Add
25 877.90K $252.12M 1.12%
1.12%
Reduce
26 10.28M $251.26M 1.11%
1.11%
Hold
27 4.61M $246.67M 1.09%
1.09%
Add
28 6.47M $218.59M 0.97%
0.97%
Add
29 5.94M $197.49M 0.88%
0.88%
Hold
30 680.87K $153.79M 0.68%
0.68%
Add
31 480.43K $127.19M 0.56%
0.56%
Add
32 4.61M $126.73M 0.56%
0.56%
Add
33 2.04M $115.99M 0.51%
0.51%
Add
34 4.55M $113.54M 0.50%
0.50%
Reduce
35 1.20M $104.57M 0.46%
0.46%
Hold
36 2.37M $76.47M 0.34%
0.34%
Hold
37 440.00K $71.05M 0.32%
0.32%
Reduce
38 820.20K $65.82M 0.29%
0.29%
Add
39 3.97M $60.92M 0.27%
0.27%
Add
40 718.12K $57.69M 0.26%
0.26%
New
41 279.70K $49.89M 0.22%
0.22%
Reduce
42 47.63M $45.13M 0.20%
0.20%
Add
43 916.80K $43.40M 0.19%
0.19%
New
44 1.60M $37.69M 0.17%
0.17%
Hold
45 255.00K $36.36M 0.16%
0.16%
Reduce
46 1.11M $30.11M 0.13%
0.13%
Hold
47 741.41K $28.46M 0.13%
0.13%
New
48 928.00K $28.11M 0.12%
0.12%
New
49 13.52K $24.49M 0.11%
0.11%
New
50 218.90K $20.61M 0.09%
0.09%
Add

FAQ

What did FARALLON CAPITAL MANAGEMENT, L.L.C. buy in 2026-Q3?

In its 2026-Q3 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. reported 109 equity positions worth $22.58B in aggregate; its largest disclosed positions were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B).

How large is FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio?

FARALLON CAPITAL MANAGEMENT, L.L.C. reported $22.58B of long equity holdings across 109 positions as of 2026-Q3. Top-10 holdings account for 62.3% of reported value.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/farallon-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →